Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from qhpeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1mq | 2 | — | — | — | — | — | — | ||
| AOD-9604 |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| 2 |
| 99.66% |
| — |
| — |
| — |
| — |
| BPC-157 | 1 | 99.59% | — | — | — | — |
| BPC-157 + TB-500 blend | 1 | — | — | — | — | — | — |
| BPC-157, TB-500, GHK-Cu, KPV | 1 | — | — | — | — | — | — |
| Cagrilintide | 1 | 99.88% | — | — | — | — |
| CJC-1295 (mod GRF 1-29) + Ipamorelin blend | 1 | — | — | — | — | — | — |
| CJC-1295 without DAC + Ipamorelin (CP10) | 1 | — | — | — | — | — | — |
| Epithalon | 1 | 99.62% | — | — | — | — |
| GHK-Cu | 1 | 99.60% | — | — | — | — |
| MOTS-C | 1 | 99.66% | — | — | — | — |
| NAD+ | 1 | — | — | — | — | — | — |
| PT-141 | 1 | 99.92% | — | — | — | — |
| Retatrutide | 2 | 99.53% | — | — | — | — |
| Selank | 1 | 99.87% | — | — | — | — |
| Semaglutide | 1 | 99.45% | — | — | — | — |
| SNAP-8 | 1 | 99.82% | — | — | — | — |
| SS-31 | 2 | 99.76% | — | — | — | — |
| Tesamorelin | 1 | 99.74% | — | — | — | — |
| Tirzepatide | 4 | 99.82% | — | — | — | — |
| Cagrilintide |
| 4 |
| Janoshik Analytical |
| 99.88% |
| — |
| 2026-04-09 |
| View |
| Selank | 4 | Janoshik Analytical | 99.87% | — | 2026-04-09 | View |
| GHK-Cu | 4 | Janoshik Analytical | 99.60% | — | 2026-04-09 | View |
| AOD-9604 | 4 | Janoshik Analytical | 99.75% | — | 2026-04-09 | View |
| PT-141 | 4 | Janoshik Analytical | 99.92% | — | 2026-04-09 | View |
| 5-Amino-1mq | 3 | Janoshik Analytical | — | — | 2026-03-16 | View |
| SS-31 | 3 | Janoshik Analytical | 99.76% | — | 2026-03-16 | View |
| BPC-157 | 3 | Janoshik Analytical | 99.59% | — | 2026-03-16 | View |
| Tirzepatide | 3 | Janoshik Analytical | 99.91% | — | 2026-03-16 | View |
| AOD-9604 | 3 | Janoshik Analytical | 99.57% | — | 2026-03-16 | View |
| CJC-1295 without DAC + Ipamorelin (CP10) | 3 | Janoshik Analytical | — | — | 2026-03-16 | View |
| Semaglutide | 3 | Janoshik Analytical | 99.45% | — | 2026-03-16 | View |
| NAD+ | 2 | Janoshik Analytical | — | — | 2026-02-19 | View |
| Tirzepatide | 2 | Janoshik Analytical | 99.90% | — | 2026-02-19 | View |
| Retatrutide | 2 | Janoshik Analytical | 99.81% | — | 2026-02-19 | View |
| 5-amino-1mq | 2 | Janoshik Analytical | — | — | 2026-02-19 | View |
| BPC-157, TB-500, GHK-Cu, KPV | 2 | Janoshik Analytical | — | — | 2026-02-16 | View |
| Tesamorelin | 2 | Janoshik Analytical | 99.74% | — | 2026-02-16 | View |
| BPC-157 + TB-500 blend | 2 | Janoshik Analytical | — | — | 2026-02-16 | View |
| CJC-1295 (mod GRF 1-29) + Ipamorelin blend | 2 | Janoshik Analytical | — | — | 2026-02-16 | View |
| SS-31 | 2 | Janoshik Analytical | 99.75% | — | 2026-02-16 | View |
| SNAP-8 | 2 | Janoshik Analytical | 99.82% | — | 2026-02-16 | View |
| Retatrutide | 12 | Janoshik Analytical | 99.24% | — | 2026-01-15 | View |
| Tirzepatide | 12 | Janoshik Analytical | 99.83% | — | 2026-01-15 | View |
Disclosed Labs